Davida Krueger
Merck & Co., Inc., Rahway, NJ, USA (United States)(US)
Publications by Year
Research Areas
Retinal Diseases and Treatments, Glaucoma and retinal disorders, Drug Solubulity and Delivery Systems, Diabetes Treatment and Management, Retinal Development and Disorders
Most-Cited Works
- → Omarigliptin (MK-3102): A Novel Long-Acting DPP-4 Inhibitor for Once-Weekly Treatment of Type 2 Diabetes(2014)167 cited
- → Agonists at the Serotonin Receptor (5-HT1A) Protect the Retina from Severe Photo-Oxidative Stress(2010)77 cited
- → Design of experiments utilization to map the processing capabilities of a micro-spray dryer: particle design and throughput optimization in support of drug discovery(2012)22 cited
- → Regulatory Considerations(2003)